IP Library Granted Patent US 11,708,567
Granted Patent B2
US 11,708,567 · App. 17/894,933 · Granted Jul 25, 2023

Engineered aryl sulfate-dependent enzymes

Inventors: Tarsis Gesteira Ferreira (Pearland, TX); Daniel H. Lajiness (Fairfield, OH)
Assignee: OPTIMVIA, LLC
C12N9/13C12N15/63C12P19/64C12Y208/02008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,708,567
App. No.
17/894,933
Granted
Jul 25, 2023
Kind
B2
Abstract

The present invention provides several non-naturally occurring sulfotransferase enzymes that have been engineered to react with aryl sulfate compounds as sulfo group donors, instead of the natural substrate 3′-phosphoadenosine 5′-phosphosulfate (PAPS), and with heparosan-based polysaccharides, particularly heparan sulfate, as sulfo group acceptors. Each of the engineered sulfotransferase enzymes have a biological activity characterized by the position within the heparosan-based polysaccharide that receives the sulfo group, including glucosaminyl N-sulfotransferase activity, hexuronyl 2-O sulfotransferase activity, glucosaminyl 6-O sulfotransferase activity, or glucosaminyl 3-O sulfotransferase activity. Methods of using the engineered sulfotransferases to produce sulfated heparosan-based polysaccharides, including polysaccharides having anticoagulant activity, are also provided.

Claims (22)

1. A method of enzymatically forming a 6-O-sulfated heparan sulfate product, the method comprising the following steps:

(a) forming a reaction mixture comprising:

(i) a sulfo group donor, the sulfo group donor consisting of an aryl sulfate compound;

(ii) heparan sulfate, wherein the heparan sulfate comprises N-,2-O-sulfated heparan sulfate (N,2O-HS); and

(iii) a non-natural glucosaminyl 6-O sulfotransferase enzyme (6OST), engineered to have sulfotransferase activity in the absence of 3′-phosphoadenosine 5′-phosphosulfate (PAPS), wherein the sulfotransferase activity comprises a transfer of the sulfo group from the aryl sulfate compound to heparan sulfate;

(b) binding the aryl sulfate compound within the enzyme active site; and

(c) catalyzing the transfer of the sulfo group from the aryl sulfate compound to the heparan sulfate, thereby forming the 6-O-sulfated heparan sulfate product.

2. The method of claim 1 , wherein the non-natural 6OST enzyme has an amino acid sequence comprising multiple mutations relative to conserved amino acid residues found in natural 6OST enzymes within enzyme class EC 2.8.2.-, wherein:

natural 6OST enzymes have sulfotransferase activity with heparan sulfate and a sulfo group donor, the sulfo group donor consisting of PAPS, to form the 6-O-sulfated heparan sulfate product; and

the amino acid sequence of the non-natural 6OST enzyme has at least 80% sequence identity with the amino acid sequence of a natural 6OST enzyme, the natural 6OST enzyme amino acid sequence selected from the group consisting of SEQ ID NO: 191, SEQ ID NO: 199, and SEQ ID NO: 201.

3. The method of claim 2 , wherein:

the natural 6OST enzyme comprises a conserved amino acid sequence motif having the amino acid sequence, SEQ ID NO: 254; and

within the amino acid sequence of the non-natural 6OST enzyme, amino acid sequence SEQ ID NO: 254 is mutated to SEQ ID NO: 257.

4. The method of claim 3 , wherein:

the natural 6OST enzyme comprises a conserved amino acid sequence motif having the amino acid sequence, SEQ ID NO: 256, and

within the amino acid sequence of the non-natural 6OST enzyme, amino acid sequence SEQ ID NO: 256 is mutated to SEQ ID NO: 260.

5. The method according to claim 2 , wherein the 6-O-sulfated heparan sulfate product comprises N-,2-O,6-O-sulfated heparan sulfate (N,2O,6O-HS).

6. The method according to claim 5 , wherein the N,2O,6O-HS product comprises at least one polysaccharide comprising a sequence motif having the structure of Formula X, below:

wherein X is either a sulfo group or an acetate group, and Y is either a sulfo group or a hydroxyl group.

7. The method of claim 2 , wherein the aryl sulfate compound is selected from the group consisting of p-nitrophenyl sulfate and 4-nitrocatechol sulfate.

8. The method of claim 2 , wherein the non-natural 6OST enzyme has at least 90% sequence identity with the amino acid sequence of the natural 6OST enzyme.

9. The method of claim 8 , wherein the natural 6OST enzyme amino acid sequence is SEQ ID NO: 191.

Assignments (2)
SECURITY INTEREST Recorded Mar 3, 2023
From: OPTIMVIA, LLC
To: GINKGO BIOWORKS, INC.
Reel/Frame 062873/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2022
From: FERREIRA, TARSIS GESTEIRA; LAJINESS, DANIEL H.
To: OPTIMVIA, LLC
Reel/Frame 060899/0395 →
Continuity (7)
Continuation 17376332 · Jul 15, 2021
Continuation In Part PCTUS2020013677 · Jan 15, 2020
Provisional Application 62792440 · Jan 15, 2019
Provisional Application 62797466 · Jan 28, 2019
Provisional Application 62808074 · Feb 20, 2019
Provisional Application 62853261 · May 28, 2019
Related Publication 20230029317A1 · Jan 26, 2023